Featured
Last news
New to The Street Show 616 Premieres Saturday on Bloomberg Television at 6:30 PM EST, Featuring HPB High Performance Battery AG With CEO Sebastian Heinz
Also featured are Banzai,PillSafe and The Sustainable Green Team
IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa
Agreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and manufacturing for priority pathogens that disproportionately impact AfricaAligns with Africa’s regional vaccine manufacturing agenda and global priorities for pandemic preparedness
FlexCare Clinicians Donate Portable Video Game Stations to Dell Children's Medical Center
The Gaming Kiosks Provide Pediatric Patients With the Opportunity to Experience the Joy of Play During Their Hospital Stay
1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report
1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to provide an update to its news release dated November 29, 2024 (the "Announcement") announcing its request for a management cease trade order (the "MCTO") relating to the late filing of the Company's audited financial statements, management discussion & analysis and applicable CEO and CFO certifications for the year ended July 31, 2024 (the "Audited Filings").
LQR House Inc. Announces Change of Ticker Symbol From "LQR" to "YHC" Effective December 16, 2024
LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that its shares of common stock will begin trading under the new ticker symbol "YHC" on the Nasdaq Capital Market prior to the market open on December 16, 2024. This change marks a strategic evolution for the Company, replacing the current ticker symbol "LQR" used since the Company's initial public offering in 2023.
Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced its participation in the Webull Corporate Connect Service (CCS). This initiative aims to further expand the Company's investor outreach and enhance transparency with its growing shareholder base.
Angle PLC Announces HER2 Presentation at SABCS
WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUMIndependent findings support ANGLE's HER2 assay development programmePotential for stratification of breast cancer patients for treatment with HER2 antibody drug conjugates
Syria's rebel victors expose ousted government's drug trade
The dramatic collapse of Bashar al-Assad's Syrian regime has thrown light into the dark corners of his rule, including the industrial-scale export of the banned drug captagon.
Prison will not silence me, Iran's Mohammadi says
Narges Mohammadi, the Iranian 2023 Nobel Peace Prize laureate on temporary medical leave from prison, said in a video call released Thursday that she would never let prison silence her.
UN investigators say 4,000 Syrian rights abusers identified
UN investigators say they have compiled secret lists of 4,000 perpetrators of serious crimes in Syria and hope the fall of Bashar al-Assad will help ensure accountability up to the highest level.
Syria govt pledges 'rule of law' after Assad's overthrow
Syria's interim government vowed on Thursday to institute the "rule of law" after years of abuses under ousted president Bashar al-Assad, as G7 powers pushed for an inclusive transition.
Fourth suspect held in deadly Dutch building collapse
Dutch police said Thursday that they had arrested a fourth suspect in connection with the deadly explosion that flattened an apartment block in The Hague, killing at least six people.
Sweden ends rape investigation allegedly targeting Kylian Mbappe
An investigation into alleged rape and sexual assault in Stockholm which Swedish media said targeted Real Madrid forward Kylian Mbappe has been closed due to insufficient evidence, the Swedish prosecutor said Thursday.
Sweden ends rape inquiry allegedly targeting Kylian Mbappe
An investigation into alleged rape and sexual assault in Stockholm which Swedish media said targeted Real Madrid forward Kylian Mbappe has been closed due to insufficient evidence, the Swedish prosecutor said Thursday.
Vulnerable Afghans struggle as Taliban rebuild Kabul roads
Mohammed Naeem knew the Kabul street where he and his brothers built matching apartment buildings was too narrow, but he was still in disbelief as their homes were reduced to rubble to widen the road.
Pope to champion popular Catholic traditions in Corsica
Pope Francis travels to the French island of Corsica Sunday to visit the small Catholic community, just days after having skipped the reopening ceremony for Notre Dame cathedral.
New Hope Network Unveils CPG and Retail Predictions for 2025
25 trends across food and beverage, beauty and personal care, wellness and supplements, consumer behavior and investment and business operations.
‘Confessions Of A CEO,’ Featuring RFK Jr., Hits Theaters In January
Deepak Chopra, Blue Zones' Dan Buettner, Tom Gegax Sound Populist Alarm
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 823,544 shares of common stock of the Company originally issued in August 2023, in November 2023, in April 2024, in July 2024 and September 2024, all at a reduced exercise price of $7.50 per share. The shares of common stock issuable upon exercise of the outstanding warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-273067), on Form S-3 (File No. 333-275710), on Form S-1 (File No. 333-278103), on Form S-1 (File No. 333-280226) and on Form S-1 (File No. 333-281892). The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $6.2 million, before deducting financial advisory fees.
Sojo Industries Partners with Blue Chip Beverage to Modernize Beverage Manufacturing
Collaboration Introduces Innovative, Modular, and Sustainable Production Solutions
Splash Beverage Group Expands Pulpoloco Sangria Distribution With Total Wine & More
Splash Beverage Group, Inc. (NYSE American:SBEV), an innovator in the beverage industry, proudly announces another 2024 retail expansion win. Total Wine & More, America's Wine Superstore and the country's largest independent retailer of fine wine, has authorized Pulpoloco Sangria across multiple states. This authorization includes Pulpoloco' Smooth Red and Crisp White Sangria varietals and spans over 115 stores in Arizona, California, Colorado, Florida, Illinois, Nevada, Texas, and Virginia.
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing mipletamig trialCohort 2 enrollment commencing
Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTDThe majority of patients in the OnTarget placebo group on abemaciclib and pertuzumab-based therapies required dose reduction or elimination
Dr. Amir Bajoghli Presents on Advancements in Dermal Fillers and Facial Danger Zones at Georgetown/MedStar Washington Hospital
Dr. Amir Bajoghli recently had the honor of presenting a comprehensive educational session at Georgetown/MedStar Washington Hospital. The presentation focused on the latest advancements in dermal fillers and identifying facial danger zones, emphasizing safe practices and innovative approaches in aesthetic medicine. This session was part of an ongoing effort to educate Georgetown University medical students and dermatology residents, sharing best practices and cutting-edge techniques.
Cellev8 Nutrition Launches the First GLP1 Support Gummy With Clinically Tested Ingredients
CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1
BlueFire Equipment Corp (BLFR) Demonstrates Progress Reporting 855.6% Growth in Q3 After Executing Its Restructuring Strategy
BlueFire Equipment Corp. (OTC Pink:BLFR) ("BLFR" or the "Company"), a specialist in emerging industry acquisitions, announces financial and operational progress on its restructuring and growth plans. As announced on July 11, 2024, BLFR acquired West Texas Dirt Movers, Inc. ("WTDM"), and Reed Exploration, LLC. As a result of the acquisitions, hiring experienced personnel into key leadership positions, and aggressively pursuing income-producing opportunities, the Company saw notable growth from second quarter to third quarter, 2024.
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr. Stephen Shoemaker as an independent director of the Company and as a member of the Company's audit committee. With this appointment, 180 is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO):
Interactive Strength Inc. (Nasdaq:TRNR) Signs Exclusive Letter of Intent to Acquire Scaled and Profitable, Connected-Fitness Equipment Business
Exclusive Non-Binding Letter of Intent signed with Target that has more than $40 million in revenue and positive EBITDA in 100% equity consideration transactionAcquisition is expected to be TRNR's second transaction within 12 MonthsAdvances strategy of using public listing to make accretive acquisitions of profitable and high-growth businesses in the highly fragmented health & wellness market globallyTarget's complementary product and customer footprint Expands TRNR's range of equipment and brands
New Syria PM says will 'guarantee' all religious groups' rights
Syria's new prime minister said the Islamist-led alliance that ousted president Bashar al-Assad will guarantee minority rights, in an interview published Wednesday, also calling on the millions who fled the war to return home.
Murder rate in Amazon far higher than rest of Brazil: study
The murder rate in Brazil's Amazon is far higher than the national average, largely because of territorial conflict in a region prey to organized crime, an NGO said Wednesday.